Use of recombinant factor VIIa in the management and prophylaxis of bleeding episodes in two patients with Bernard-Soulier syndrome.
Hacihanefioglu
Abdullah
A
Tarkun
Pinar
P
Gonullu
Emel
E
D000328:Adult; D001606:Bernard-Soulier Syndrome / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D001780:Blood Coagulation Tests; D004844:Epistaxis / Q000209:etiology / Q000628:therapy*; D017707:Erythrocyte Transfusion; D005167:Factor VII / Q000008:administration & dosage*; D005260:Female; D005434:Flow Cytometry; D005773:Gastroscopy; D006801:Humans; D007902:Length of Stay; D008297:Male; D008595:Menorrhagia / Q000209:etiology / Q000628:therapy; D019038:Platelet Glycoprotein GPIb-IX Complex; D010980:Platelet Membrane Glycoproteins / Q000172:deficiency; D017713:Platelet Transfusion; D011994:Recombinant Proteins / Q000008:administration & dosage; D016896:Treatment Outcome
D019038:Platelet Glycoprotein GPIb-IX Complex; D010980:Platelet Membrane Glycoproteins; D011994:Recombinant Proteins; C032193:glycoprotein receptor GPIb-IX; D005167:Factor VII